Dexin Yu Selected Research

Dexin Yu Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 02/2006
17	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 09/2015
6	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2006
6	Kidney Neoplasms (Kidney Cancer) 01/2023 - 03/2018
5	Carcinoma (Carcinomatosis) 01/2022 - 06/2008
4	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 11/2014
4	Carcinogenesis 02/2021 - 01/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 07/2015
3	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2018
3	Adenocarcinoma 03/2023 - 11/2021
3	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 08/2011
2	Pathologic Constriction (Stenosis) 02/2023 - 04/2021
2	Pain (Aches) 11/2022 - 01/2022
2	Reperfusion Injury 05/2022 - 01/2022
2	Infections 01/2022 - 04/2021
2	Urinary Calculi (Urinary Calculus) 01/2022 - 04/2021
2	Pathologic Dilatation (Ectasia) 02/2018 - 01/2015
1	Hypoxia (Hypoxemia) 01/2024
1	Inflammation (Inflammations) 12/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Overweight 10/2023
1	Hyperlipidemias (Hyperlipidemia) 08/2023
1	Non-alcoholic Fatty Liver Disease 08/2023
1	Fatty Liver 08/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Margins of Excision 12/2022
1	Hemospermia 11/2022
1	Splenic Rupture 11/2022
1	Acute Kidney Injury (Acute Renal Failure) 05/2022
1	Ischemia 05/2022
1	Vitamin D Deficiency 05/2022

Drug/Important Bio-Agent (IBA)

10	SmokeIBA 11/2020 - 09/2015
8	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2017
6	Contrast MediaIBA 03/2017 - 08/2011
5	Gadolinium DTPA (Magnevist)FDA Link 01/2017 - 03/2009
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2021
4	benzidineIBA 02/2021 - 04/2017
4	AcidsIBA 01/2017 - 11/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2017
3	IonsIBA 03/2024 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2008
3	CurcuminIBA 01/2020 - 04/2017
3	GadoliniumIBA 05/2013 - 03/2009
2	IronIBA 03/2024 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2021
2	AndrogensIBA 03/2022 - 12/2017
2	ResveratrolIBA 01/2021 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 02/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 01/2017
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 02/2018 - 01/2015
2	Protein Kinases (Protein Kinase)IBA 04/2017 - 02/2017
2	Lysine (L-Lysine)FDA Link 03/2017 - 01/2017
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2017 - 08/2011
2	SolutionsIBA 05/2016 - 03/2014
2	ChitosanIBA 08/2015 - 05/2013
1	manganese dioxideIBA 01/2024
1	Peroxidase (Myeloperoxidase)IBA 01/2024
1	arginyl-glycyl-aspartic acidIBA 01/2024
1	LigandsIBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	Cystatin CIBA 11/2023
1	Hormones (Hormone)IBA 10/2023
1	LipidsIBA 08/2023
1	thymoquinoneIBA 08/2023
1	oxidized low density lipoproteinIBA 08/2023
1	Transforming Growth Factor-beta Type I ReceptorIBA 03/2023
1	Androgen Receptors (Androgen Receptor)IBA 03/2023
1	Origin Recognition ComplexIBA 03/2023
1	DNA (Deoxyribonucleic Acid)IBA 03/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	camrelizumabIBA 01/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	diallyl trisulfideIBA 01/2023
1	apatinibIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Cholecalciferol (Vitamin D3)FDA Link 05/2022
1	CytokinesIBA 05/2022
1	Interleukin-18 (Interleukin 18)IBA 05/2022
1	enzalutamideIBA 03/2022
1	Circular RNAIBA 03/2022
1	MicroRNAs (MicroRNA)IBA 03/2022

Therapy/Procedure

19	Therapeutics 03/2024 - 02/2006
6	Drug Therapy (Chemotherapy) 01/2024 - 10/2019
5	Precision Medicine 01/2024 - 03/2014
5	Nephrectomy 01/2022 - 07/2015
3	Immunotherapy 04/2024 - 01/2023
3	Photothermal Therapy 01/2023 - 10/2014
3	Lasers (Laser) 12/2020 - 10/2014
2	Operative Time 02/2023 - 11/2021
2	Urinary Diversion (Ileal Conduit) 11/2021 - 04/2021
1	Stents 12/2023
1	Gastrectomy 10/2023
1	Bariatric Surgery 10/2023
1	Neoadjuvant Therapy 01/2023
1	Hepatectomy 12/2022
1	Splenectomy 11/2022
1	Castration 03/2022